Sagimet Biosciences (SGMT) Return on Assets [ROA] (2023 - 2026)
Sagimet Biosciences (SGMT) reported Return on Assets [ROA] of -25.37% for Q2 2026, up 16.51 percentage points from -41.88% a year earlier and up 13.44 percentage points from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Sagimet Biosciences posted Return on Assets [ROA] of -36.89%, down 1.42 percentage points from FY2024.
- By year, Return on Assets [ROA] came in at -35.46% in FY2024 (+7.51 pp) and -42.97% in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q3 2024.
- Year over year, Return on Assets [ROA] gained in three of the last eight quarters, with an average year-over-year change of -5.45 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q3 2024 (a gain of 22.65 percentage points); the low point was Q2 2025 (a drop of 26.62 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -38.81% (Q1 2026), -41.68% (Q4 2025) and -43.39% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Sagimet Biosciences | 485.47 Mn | 485.47 Mn | - | -25.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.37% |
| Mar 31, 2026 | -38.81% |
| Dec 31, 2025 | -41.68% |
| Sep 30, 2025 | -43.39% |
| Jun 30, 2025 | -41.88% |
| Mar 31, 2025 | -37.28% |
| Dec 31, 2024 | -27.20% |
| Sep 30, 2024 | -20.63% |
| Jun 30, 2024 | -15.26% |
| Mar 31, 2024 | -19.17% |
| Dec 31, 2023 | -27.93% |
| Sep 30, 2023 | -43.27% |
API Access
Sagimet Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();